Trending stocks

CanaDream Corp reports 53.4% Net Income growth and 28.8% Revenue growth

07.07.2016 • About CanaDream Corp ($CDN) • By InTwits

CanaDream Corp reported FY2016 financial results today. Overall the company's long term financial model is characterised by the following facts:
  • CanaDream Corp is a growth stock: FY2016 revenue growth was 28.8%, 5 year revenue CAGR was 12.0% at FY2016 ROIC 10.0%
  • CanaDream Corp has high CAPEX intensity: 5 year average CAPEX/Revenue was 55.9%. At the same time it's a lot of higher than industry average of 3.1%.
  • CAPEX is quite volatile: 28.2 in FY2016, 21.6 in FY2015, 20.6 in FY2014, 10.6 in FY2013, 11.5 in FY2012
  • The company has business model with average profitability: ROIC is at 10.0%
Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.

CanaDream Corp ($CDN) key annual financial indicators

mln. CAD201220132014201520162016/2015
P&L
Revenue26.49227.83629.27634.11143.92328.8%
Gross Profit8.9198.7609.38410.80014.35032.9%
EBITDA6.4706.3927.3067.42510.06335.5%
Net Income1.0930.6081.1332.1283.26453.4%
Balance Sheet
Cash3.0292.8833.7436.9386.868-1.0%
Short Term Debt16.49014.92913.14215.22413.674-10.2%
Long Term Debt7.0126.70813.40915.78117.93913.7%
Cash flow
Capex11.46310.59420.60021.63628.19030.3%
Ratios
Revenue growth6.1%5.1%5.2%16.5%28.8%
EBITDA growth7.1%-1.2%14.3%1.6%35.5%
Gross Margin33.7%31.5%32.1%31.7%32.7%1.0%
EBITDA Margin24.4%23.0%25.0%21.8%22.9%1.1%
Net Income Margin4.1%2.2%3.9%6.2%7.4%1.2%
CAPEX, % of revenue43.3%38.1%70.4%63.4%64.2%0.8%
ROIC7.2%5.8%7.8%7.5%10.0%2.5%
ROE11.5%5.9%10.2%16.6%20.9%4.3%
Net Debt/EBITDA3.2x2.9x3.1x3.2x2.5x-0.8x


CanaDream Corp ($CDN) key quoterly financial indicators

mln. CADFY16Q1FY16Q2FY16Q3FY16Q4YoY change
P&L
Revenue14165913.6%30.3%27.0%60.4%
EBITDA67-2-120.5%28.5%
Net Income35-3-218.7%61.7%
Balance Sheet
Cash1696738.3%21.0%94.8%-1.0%
Short Term Debt232018148.5%-3.4%5.4%-10.2%
Long Term Debt2622201866.9%69.9%69.3%13.7%
Ratios
Gross Margin52.3%51.2%-18.3%-29.7%1.4%-1.2%4.5%-12.9%
EBITDA Margin 44.4% 43.2% -30.5% -15.7%2.6%-0.6%5.5%13.1%
Net Income Margin 23.4% 28.9% -51.4% -22.2%1.0%5.6%-11.1%11.1%

Revenue and profitability


CanaDream Corp's Revenue surged on 28.8%. Revenue growth showed acceleration in FY16Q4 - it increased 60.4% YoY. Having declining revenue the company managed to increase EBITDA margin. EBITDA Margin increased slightly on 0.83 pp from 1.0% to 1.9% in FY2016.

Gross Margin increased slightly on 1.0 pp from 31.7% to 32.7% in FY2016.

Net Income marign increased slightly on 1.2 pp from 6.2% to 7.4% in FY2016.

Capital expenditures (CAPEX) and working capital investments


In FY2016 CanaDream Corp had CAPEX/Revenue of 64.2%. CAPEX/Revenue surged on 26.1 pp from 38.1% in FY2013 to 64.2% in FY2016. For the last three years the average CAPEX/Revenue was 66.0%.To secure this fast growth CanaDream Corp made large investments to CAPEX (280% of EBITDA).

Return on investment


The company operates at good ROE (20.89%) while ROIC is low (10.03%). ROIC increased on 2.5 pp from 7.5% to 10.0% in FY2016. ROE increased on 4.3 pp from 16.6% to 20.9% in FY2016.

Leverage (Debt)


Debt level is 2.5x Net Debt / EBITDA and 3.1x Debt / EBITDA. Net Debt / EBITDA dropped on 0.8x from 3.2x to 2.5x in FY2016. Debt increased slightly on 2.0% while cash decreased slightly on 1.0%.

Appendix 1: Peers in Consumer, Non-cyclical


Below you can find CanaDream Corp benchmarking vs. other companies in Consumer, Non-cyclical industry. It's shown for the period of 5 years for the key financial metrics. Each table has median value for all the companies in the industry together with individual financial data of the top-5 companies in the industry by particular financial metric.

Top companies by Revenue growth, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Concordia Healthcare Corp ($CXR)159.5%275.7%107.0%
Heritage Global Inc ($HGP)-37.0%76.2%11.2%80.8%
EnerCare Inc ($ECI)8.6%21.1%55.7%76.6%
CRH Medical Corp ($CRH)12.5%56.0%284.2%70.2%
Nuvo Research Inc ($NRI)-25.3%-29.1%57.0%31.9%
 
Median (41 companies)8.6%13.8%15.2%12.8%


Top companies by Gross margin, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Cipher Pharmaceuticals Inc ($CPH)99.5%98.3%92.7%
Ritchie Bros Auctioneers Inc ($RBA)88.7%88.4%88.0%89.1%88.3%
Information Services Corp ($ISV)77.5%80.4%80.9%87.6%85.1%
Biosyent Inc ($RX)79.3%79.2%78.1%78.7%
Concordia Healthcare Corp ($CXR)79.4%86.0%76.1%72.9%
 
Median (35 companies)32.5%37.1%35.7%35.7%31.1%


Top companies by EBITDA margin, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
CRH Medical Corp ($CRH)21.0%24.5%29.1%44.1%
Valeant Pharmaceuticals International Inc ($VRX)30.6%27.8%45.6%39.8%23.8%
Concordia Healthcare Corp ($CXR)43.7%37.0%39.8%-92.8%
Ritchie Bros Auctioneers Inc ($RBA)36.8%36.3%36.4%39.7%31.4%
EnerCare Inc ($ECI)52.8%51.0%45.5%39.3%26.6%
 
Median (44 companies)9.2%12.4%13.4%11.8%10.1%


Top companies by CAPEX/Revenue, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
ProMetic Life Sciences Inc ($PLI)2.1%33.6%34.6%23.3%
EnerCare Inc ($ECI)25.7%26.5%23.6%20.7%15.5%
Black Diamond Group Ltd ($BDI)61.9%27.5%31.0%17.6%
easyhome Ltd ($EH)32.2%25.6%21.6%16.9%12.7%
K-Bro Linen Inc ($KBL)10.0%19.0%11.4%16.6%
 
Median (43 companies)3.1%2.7%2.3%2.4%2.1%


Top companies by ROIC, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Information Services Corp ($ISV)71.8%72.8%58.9%38.1%27.6%
Colliers International Group Inc ($CIG)10.5%11.2%15.2%10.9%26.1%
Nuvo Research Inc ($NRI)-11.6%-17.4%-37.9%12.9%20.8%
International Road Dynamics Inc ($IRD)0.9%6.7%4.4%10.6%16.5%
Premium Brands Holdings Corp ($PBH)10.3%9.9%6.9%12.6%15.3%
 
Median (44 companies)8.8%8.4%8.4%6.9%8.0%


Top companies by Net Debt / EBITDA

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Concordia Healthcare Corp ($CXR)-1.3x5.6x20.2x
SunOpta Inc ($SOY)2.9x3.5x1.3x16.9x140.8x
Centric Health Corp ($CHH)5.6x10.2x11.2x15.6x
Sienna Senior Living Inc ($SIA)9.5x11.8x9.2x9.1x9.1x
Valeant Pharmaceuticals International Inc ($VRX)9.5x10.4x4.0x7.3x12.7x
 
Median (38 companies)2.8x2.3x3.4x2.5x2.8x